• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新冠疫苗公平性陷入困境:治理不善

COVID-19 vaccine equity in doldrums: Good governance deficits.

作者信息

Bhuiyan Shahjahan

机构信息

Department of Public Policy and Administration, School of Global Affairs and Public Policy (GAPP) The American University in Cairo New Cairo Egypt.

出版信息

Public Adm Dev. 2022 Dec;42(5):293-304. doi: 10.1002/pad.1999. Epub 2022 Dec 4.

DOI:10.1002/pad.1999
PMID:36718258
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9878060/
Abstract

This paper explores whether inequities in access to COVID-19 vaccines can be attributed to governance deficits, particularly for developing and emerging countries where poor governance is widespread, but also for developed countries, where governments' performance fell short of expectations. These shared performance deficits beg questions about the impact of governance quality as well as the interplay of ethics in governance when life-or-death decisions must be made. It also explores the impact of COVID-19 on development, especially in the areas of poverty and employment. The findings of the paper show that there is a positive correlation between vaccine equity and good governance, meaning that countries with higher scores in governance rankings have more access to vaccines and have vaccinated most of their populations. Similarly, countries with relatively lower scores in governance rankings have poor access to and distribution of vaccines and have only covered a limited number of their people. The paper further points to disastrous societal impacts of COVID-19 vaccine inequity on poverty and employment, which have hindered global development.

摘要

本文探讨了获得新冠疫苗方面的不平等现象是否可归因于治理缺陷,这一现象在治理不善普遍存在的发展中国家和新兴国家尤为突出,在发达国家也存在,其政府表现未达预期。这些共同的表现缺陷引发了关于治理质量的影响以及在必须做出生死抉择时治理中伦理相互作用的问题。本文还探讨了新冠疫情对发展的影响,尤其是在贫困和就业领域。该论文的研究结果表明,疫苗公平性与良好治理之间存在正相关关系,这意味着在治理排名中得分较高的国家更容易获得疫苗,并且其大部分人口都已接种。同样,在治理排名中得分相对较低的国家,疫苗获取和分配情况较差,仅覆盖了有限数量的人口。该论文进一步指出,新冠疫苗不平等对贫困和就业产生了灾难性的社会影响,阻碍了全球发展。

相似文献

1
COVID-19 vaccine equity in doldrums: Good governance deficits.新冠疫苗公平性陷入困境:治理不善
Public Adm Dev. 2022 Dec;42(5):293-304. doi: 10.1002/pad.1999. Epub 2022 Dec 4.
2
COVID-19 vaccine apartheid and the failure of global cooperation.新冠疫苗种族隔离与全球合作的失败
Br J Polit Int Relat. 2023 Aug;25(3):535-554. doi: 10.1177/13691481231178248. Epub 2023 Jun 13.
3
Global vaccine inequities and multilateralism amid COVID-19: Reconnaissance of Global Health Diplomacy as a panacea?新冠疫情期间的全球疫苗不平等与多边主义:将全球卫生外交视为万灵药的审视?
Health Promot Perspect. 2022 Dec 31;12(4):315-324. doi: 10.34172/hpp.2022.41. eCollection 2022.
4
Redressing COVID-19 vaccine inequity amidst booster doses: charting a bold path for global health solidarity, together.在加强针接种之际纠正 COVID-19 疫苗不平等现象:为全球卫生团结绘制大胆路线,共同努力。
Global Health. 2022 Feb 22;18(1):23. doi: 10.1186/s12992-022-00817-5.
5
Governance for planetary health equity-the Planetary Health Equity Hothouse project.促进行星健康公平的治理——行星健康公平温室项目。
Lancet Planet Health. 2024 Apr;8 Suppl 1:S15. doi: 10.1016/S2542-5196(24)00080-9.
6
Cross-country evidence on the role of national governance in boosting COVID-19 vaccination.跨国证据表明,国家治理在推动 COVID-19 疫苗接种方面发挥了作用。
BMC Public Health. 2022 Mar 23;22(1):576. doi: 10.1186/s12889-022-12985-5.
7
COVID-19 vaccine equity: a health systems and policy perspective.COVID-19 疫苗公平性:从卫生系统和政策角度看。
Expert Rev Vaccines. 2022 Jan;21(1):25-36. doi: 10.1080/14760584.2022.2004125. Epub 2021 Nov 25.
8
COVID-19 vaccination and governance in the case of low, middle and high-income countries.新冠病毒疫苗接种和低、中、高收入国家的治理。
BMC Public Health. 2023 Jun 5;23(1):1073. doi: 10.1186/s12889-023-15975-3.
9
Global health governance performance during Covid-19, what needs to be changed? a delphi survey study.新冠疫情期间全球卫生治理表现如何?有何改善之处?德尔菲调查研究
Global Health. 2023 Mar 31;19(1):24. doi: 10.1186/s12992-023-00921-0.
10
[Dilemma, causes and countermeasures of global health governance: taking COVID-19 Vaccines Global Access Facility as an example].[全球卫生治理的困境、成因与对策:以新冠疫苗全球获取机制为例]
Zhonghua Liu Xing Bing Xue Za Zhi. 2022 Apr 10;43(4):483-487. doi: 10.3760/cma.j.cn112338-20211216-00987.

本文引用的文献

1
Online misinformation is linked to early COVID-19 vaccination hesitancy and refusal.网络错误信息与早期 COVID-19 疫苗犹豫和拒绝有关。
Sci Rep. 2022 Apr 26;12(1):5966. doi: 10.1038/s41598-022-10070-w.
2
Vaccine Hesitancy Among Religious Groups: Reasons Underlying This Phenomenon and Communication Strategies to Rebuild Trust.宗教群体中的疫苗犹豫:这一现象背后的原因及重建信任的沟通策略
Front Public Health. 2022 Feb 7;10:824560. doi: 10.3389/fpubh.2022.824560. eCollection 2022.
3
The role of good governance in the race for global vaccination during the COVID-19 pandemic.良好治理在 COVID-19 大流行期间全球疫苗接种竞赛中的作用。
Sci Rep. 2021 Nov 17;11(1):22440. doi: 10.1038/s41598-021-01831-0.
4
COVID-19 vaccine equity: a health systems and policy perspective.COVID-19 疫苗公平性:从卫生系统和政策角度看。
Expert Rev Vaccines. 2022 Jan;21(1):25-36. doi: 10.1080/14760584.2022.2004125. Epub 2021 Nov 25.
5
COVAX and the rise of the 'super public private partnership' for global health.新冠疫苗全球免疫合作机制(COVAX)与全球卫生领域“超级公私伙伴关系”的兴起。
Glob Public Health. 2023 Jan;18(1):1987502. doi: 10.1080/17441692.2021.1987502. Epub 2021 Oct 22.
6
Vaccine nationalism and internationalism: perspectives of COVID-19 vaccine trial participants in the United Kingdom.疫苗民族主义与国际主义:英国 COVID-19 疫苗试验参与者的观点。
BMJ Glob Health. 2021 Oct;6(10). doi: 10.1136/bmjgh-2021-006305.
7
Exposing the Unfinished Business of Building Public Administration in Late Democracies: Lessons from the COVID-19 Response in Brazil.揭示晚期民主国家公共行政建设的未竟事业:来自巴西应对新冠疫情的教训
Public Adm Rev. 2021 Nov-Dec;81(6):1183-1191. doi: 10.1111/puar.13415. Epub 2021 Aug 24.
8
COVID-19 vaccines a global public good? Moving past the rhetoric and making work of sharing intellectual property rights, know-how and technology.新冠疫苗是全球公共产品?摒弃空谈,推动知识产权、专有技术和技术共享工作。
Eur J Public Health. 2021 Oct 26;31(5):925-926. doi: 10.1093/eurpub/ckab144.
9
COVID-19 challenges and its therapeutics.COVID-19 挑战及其治疗方法。
Biomed Pharmacother. 2021 Oct;142:112015. doi: 10.1016/j.biopha.2021.112015. Epub 2021 Aug 5.
10
Measuring and Promoting SARS-CoV-2 Vaccine Equity: Development of a COVID-19 Vaccine Equity Index.衡量和促进新冠病毒疫苗公平性:新冠疫苗公平性指数的制定
Health Equity. 2021 Jul 13;5(1):476-483. doi: 10.1089/heq.2021.0047. eCollection 2021.